News & Media

ALL Featured 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Globally, the diabetic nephropathy market is witnessing significant growth due to rise in the incide...

Building on the company’s recent licensing deals for PromarkerD as a predictive test for diabetic ki...

Proteomics International is delighted to announce a major milestone in the on-going commercialisatio...

Building on the company’s recent licensing deals for PromarkerD as a predictive test for diabetic ki...

Adding to our recent successes with licencing PromarkerD into the USA and Mexico, we are pleased to ...

The Company announces that its balance sheet has been strengthened by the receipt of over $800,000 i...

The company advises it has completed the sale of its shareholding in CPR Pharma Services Pty Ltd (CP...

Proteomics International and Irish clinical diagnostics company Atturos have signed a Memorandum of ...

Proteomics International Laboratories Ltd (ASX:PIQ) has boosted its balance sheet with the sale of i...

Proteomics International announces it will receive a boost to its balance sheet with the cash sale o...

A new Australian-developed blood test could help 30 million American diabetics predict whether they ...

Building on our recent successes with licencing PromarkerD into the USA and Mexico, Proteomics Inter...

https://youtu.be/OBObYp6tt-U

Proteomics International has been granted a patent for its pioneering diagnostic and predictive test...

Proteomics International has secured a contract with Dutch/Australian company BiosanaPharma to condu...

With exciting back to back licences for PromarkerD in the USA and Mexico, Proteomics International M...

Proteomics International is pleased to announce the third licensing deal for PromarkerD, with our wo...

The Research and Development Tax Incentive has helped establish Proteomics International to become t...

Proteomics International Ltd (Proteomics International; ASX: PIQ) has signed the first licence agree...

Medical technology company Proteomics International Laboratories (ASX: PIQ) has announced a signific...

Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX:...

Proteomics International featured on SkyBusiness news Wednesday afternoon with Tony Locantro from Al...

Proteomics International featured on the radio Friday morning with The Naked Scientist talking about...

I am delighted to advise that our options exercise will raise the maximum available amount of $3.4 m...

PERTH, W. AUSTRALIA, Mar 20, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International Labora...

PromarkerD, the world leading predictive diagnostic test for DKD, launched in Dominican Republic thi...

PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International Laboratories Ltd (Proteomics Internat...

MedTech pioneer Proteomics International Laboratories Ltd has launched PromarkerD which is world lea...

PromarkerD, the world leading predictive diagnostic test for DKD, launched in Dominican Republic thi...

MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with...

PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a s...

Medtech pioneer Proteomics International has entered into a strategic alliance with fellow Australia...

PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International (PILL;...

NEW YORK (GenomeWeb) – Proteomics International said today it has entered a strategic alliance with ...

Overnight the official product launch of PromarkerD has taken place in the Dominican Republic. This ...

Proteomics International is excited to announce a strategic alliance with clinical services company ...

Proteomics International has been granted a patent in Japan for the company’s world leading diagnost...

Media Coverage